ID   PTGR1_HUMAN             Reviewed;         329 AA.
AC   Q14914; A8K0N2; B4DPK3; F5GY50; Q8IYQ0; Q9H1X6;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2002, sequence version 2.
DT   10-MAY-2017, entry version 167.
DE   RecName: Full=Prostaglandin reductase 1;
DE            Short=PRG-1;
DE            EC=1.3.1.-;
DE   AltName: Full=15-oxoprostaglandin 13-reductase;
DE            EC=1.3.1.48;
DE   AltName: Full=NADP-dependent leukotriene B4 12-hydroxydehydrogenase;
DE            EC=1.3.1.74;
GN   Name=PTGR1; Synonyms=LTB4DH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   SER-27.
RC   TISSUE=Brain cortex, and Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT SER-27.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   SER-27.
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-311 (ISOFORM 1), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=8576264; DOI=10.1074/jbc.271.5.2844;
RA   Yokomizo T., Ogawa Y., Uozumi N., Kume K., Izumi T., Shimizu T.;
RT   "cDNA cloning, expression, and mutagenesis study of leukotriene B4 12-
RT   hydroxydehydrogenase.";
RL   J. Biol. Chem. 271:2844-2850(1996).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-18 AND SER-20, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 4-239.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human NADP-dependent leukotriene B4 12-
RT   hydroxydehydrogenase.";
RL   Submitted (MAY-2005) to the PDB data bank.
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 4-329 IN COMPLEX WITH NADP
RP   AND RALOXIFENE.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human leukotriene B4 12-hydroxydehydrogenase in
RT   complex with NADP and raloxifene.";
RL   Submitted (JAN-2011) to the PDB data bank.
CC   -!- FUNCTION: Functions as 15-oxo-prostaglandin 13-reductase and acts
CC       on 15-oxo-PGE1, 15-oxo-PGE2 and 15-oxo-PGE2-alpha. Has no activity
CC       towards PGE1, PGE2 and PGE2-alpha (By similarity). Catalyzes the
CC       conversion of leukotriene B4 into its biologically less active
CC       metabolite, 12-oxo-leukotriene B4. This is an initial and key step
CC       of metabolic inactivation of leukotriene B4. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: A n-alkanal + NAD(P)(+) = an alk-2-enal +
CC       NAD(P)H.
CC   -!- CATALYTIC ACTIVITY: 11-alpha-hydroxy-9,15-dioxoprost-5-enoate +
CC       NAD(P)(+) = (5Z)-(13E)-11-alpha-hydroxy-9,15-dioxoprosta-5,13-
CC       dienoate + NAD(P)H.
CC   -!- SUBUNIT: Monomer or homodimer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q14914-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14914-2; Sequence=VSP_044652;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: High expression in the kidney, liver, and
CC       intestine but not in leukocytes. {ECO:0000269|PubMed:8576264}.
CC   -!- SIMILARITY: Belongs to the NADP-dependent oxidoreductase L4BD
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK289597; BAF82286.1; -; mRNA.
DR   EMBL; AK298379; BAG60615.1; -; mRNA.
DR   EMBL; AL135787; CAC22151.1; -; Genomic_DNA.
DR   EMBL; AL159168; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471105; EAW59074.1; -; Genomic_DNA.
DR   EMBL; BC035228; AAH35228.1; -; mRNA.
DR   EMBL; D49387; BAA08382.1; -; mRNA.
DR   CCDS; CCDS55331.1; -. [Q14914-2]
DR   CCDS; CCDS6779.1; -. [Q14914-1]
DR   RefSeq; NP_001139580.1; NM_001146108.1. [Q14914-1]
DR   RefSeq; NP_001139581.1; NM_001146109.1. [Q14914-2]
DR   RefSeq; NP_036344.2; NM_012212.3. [Q14914-1]
DR   UniGene; Hs.584864; -.
DR   PDB; 1ZSV; X-ray; 2.30 A; A/B/C/D=4-329.
DR   PDB; 2Y05; X-ray; 2.20 A; A/B/C/D=4-329.
DR   PDBsum; 1ZSV; -.
DR   PDBsum; 2Y05; -.
DR   ProteinModelPortal; Q14914; -.
DR   SMR; Q14914; -.
DR   BioGrid; 116604; 14.
DR   IntAct; Q14914; 2.
DR   MINT; MINT-5004604; -.
DR   STRING; 9606.ENSP00000311572; -.
DR   DrugBank; DB03461; 2'-Monophosphoadenosine 5'-Diphosphoribose.
DR   DrugBank; DB04066; Para-Coumaric Acid.
DR   SwissLipids; SLP:000001629; -.
DR   iPTMnet; Q14914; -.
DR   PhosphoSitePlus; Q14914; -.
DR   BioMuta; PTGR1; -.
DR   DMDM; 23503081; -.
DR   EPD; Q14914; -.
DR   MaxQB; Q14914; -.
DR   PaxDb; Q14914; -.
DR   PeptideAtlas; Q14914; -.
DR   PRIDE; Q14914; -.
DR   TopDownProteomics; Q14914-1; -. [Q14914-1]
DR   Ensembl; ENST00000309195; ENSP00000311572; ENSG00000106853. [Q14914-1]
DR   Ensembl; ENST00000407693; ENSP00000385763; ENSG00000106853. [Q14914-1]
DR   GeneID; 22949; -.
DR   KEGG; hsa:22949; -.
DR   UCSC; uc004bfh.3; human. [Q14914-1]
DR   CTD; 22949; -.
DR   DisGeNET; 22949; -.
DR   GeneCards; ENSG00000283263; -.
DR   GeneCards; PTGR1; -.
DR   H-InvDB; HIX0008283; -.
DR   HGNC; HGNC:18429; PTGR1.
DR   HPA; HPA036724; -.
DR   MIM; 601274; gene.
DR   neXtProt; NX_Q14914; -.
DR   OpenTargets; ENSG00000106853; -.
DR   OpenTargets; ENSG00000283263; -.
DR   PharmGKB; PA162400322; -.
DR   eggNOG; KOG1196; Eukaryota.
DR   eggNOG; COG2130; LUCA.
DR   GeneTree; ENSGT00390000009335; -.
DR   HOGENOM; HOG000294663; -.
DR   HOVERGEN; HBG055024; -.
DR   InParanoid; Q14914; -.
DR   KO; K13948; -.
DR   OMA; MGMPGFT; -.
DR   OrthoDB; EOG091G0F5B; -.
DR   PhylomeDB; Q14914; -.
DR   TreeFam; TF324201; -.
DR   Reactome; R-HSA-2142691; Synthesis of Leukotrienes (LT) and Eoxins (EX).
DR   Reactome; R-HSA-2142700; Synthesis of Lipoxins (LX).
DR   ChiTaRS; PTGR1; human.
DR   EvolutionaryTrace; Q14914; -.
DR   GenomeRNAi; 22949; -.
DR   PRO; PR:Q14914; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000106853; -.
DR   CleanEx; HS_PTGR1; -.
DR   ExpressionAtlas; Q14914; baseline and differential.
DR   Genevisible; Q14914; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0036132; F:13-prostaglandin reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0047522; F:15-oxoprostaglandin 13-oxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0032440; F:2-alkenal reductase [NAD(P)] activity; IEA:UniProtKB-EC.
DR   GO; GO:0006691; P:leukotriene metabolic process; NAS:UniProtKB.
DR   GO; GO:0097327; P:response to antineoplastic agent; IEA:Ensembl.
DR   InterPro; IPR013149; ADH_C.
DR   InterPro; IPR014190; B4_12hDH.
DR   InterPro; IPR011032; GroES-like.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR020843; PKS_ER.
DR   Pfam; PF00107; ADH_zinc_N; 1.
DR   SMART; SM00829; PKS_ER; 1.
DR   SUPFAM; SSF50129; SSF50129; 2.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   TIGRFAMs; TIGR02825; B4_12hDH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; NADP; Oxidoreductase; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    329       Prostaglandin reductase 1.
FT                                /FTId=PRO_0000218065.
FT   NP_BIND     152    155       NADP. {ECO:0000269|Ref.9}.
FT   NP_BIND     239    245       NADP. {ECO:0000269|Ref.9}.
FT   NP_BIND     270    272       NADP. {ECO:0000269|Ref.9}.
FT   COMPBIAS    250    257       Pro-rich.
FT   BINDING     178    178       NADP. {ECO:0000269|Ref.9}.
FT   BINDING     193    193       NADP. {ECO:0000269|Ref.9}.
FT   BINDING     217    217       NADP. {ECO:0000269|Ref.9}.
FT   BINDING     321    321       NADP. {ECO:0000269|Ref.9}.
FT   MOD_RES      18     18       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      20     20       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     178    178       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q91YR9}.
FT   VAR_SEQ     294    329       GKIQYKEYIIEGFENMPAAFMGMLKGDNLGKTIVKA -> I
FT                                KRENEED (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044652.
FT   VARIANT      27     27       A -> S (in dbSNP:rs1053959).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_023111.
FT   CONFLICT    311    311       A -> R (in Ref. 5; BAA08382).
FT                                {ECO:0000305}.
FT   STRAND        4     11       {ECO:0000244|PDB:2Y05}.
FT   STRAND       14     16       {ECO:0000244|PDB:2Y05}.
FT   HELIX        19     21       {ECO:0000244|PDB:2Y05}.
FT   STRAND       22     28       {ECO:0000244|PDB:2Y05}.
FT   STRAND       37     45       {ECO:0000244|PDB:2Y05}.
FT   HELIX        49     53       {ECO:0000244|PDB:2Y05}.
FT   HELIX        54     56       {ECO:0000244|PDB:2Y05}.
FT   STRAND       67     75       {ECO:0000244|PDB:2Y05}.
FT   STRAND       84     87       {ECO:0000244|PDB:2Y05}.
FT   STRAND       91     97       {ECO:0000244|PDB:2Y05}.
FT   HELIX       115    119       {ECO:0000244|PDB:2Y05}.
FT   TURN        120    122       {ECO:0000244|PDB:2Y05}.
FT   HELIX       124    134       {ECO:0000244|PDB:2Y05}.
FT   STRAND      144    149       {ECO:0000244|PDB:2Y05}.
FT   HELIX       153    164       {ECO:0000244|PDB:2Y05}.
FT   STRAND      168    175       {ECO:0000244|PDB:2Y05}.
FT   HELIX       176    185       {ECO:0000244|PDB:2Y05}.
FT   STRAND      188    192       {ECO:0000244|PDB:2Y05}.
FT   TURN        193    195       {ECO:0000244|PDB:2Y05}.
FT   HELIX       199    206       {ECO:0000244|PDB:2Y05}.
FT   STRAND      211    218       {ECO:0000244|PDB:2Y05}.
FT   HELIX       220    227       {ECO:0000244|PDB:2Y05}.
FT   STRAND      230    238       {ECO:0000244|PDB:2Y05}.
FT   HELIX       242    245       {ECO:0000244|PDB:2Y05}.
FT   HELIX       257    262       {ECO:0000244|PDB:2Y05}.
FT   STRAND      266    269       {ECO:0000244|PDB:2Y05}.
FT   HELIX       272    274       {ECO:0000244|PDB:2Y05}.
FT   HELIX       277    292       {ECO:0000244|PDB:2Y05}.
FT   STRAND      300    304       {ECO:0000244|PDB:2Y05}.
FT   HELIX       306    308       {ECO:0000244|PDB:2Y05}.
FT   HELIX       309    317       {ECO:0000244|PDB:2Y05}.
FT   STRAND      322    328       {ECO:0000244|PDB:2Y05}.
SQ   SEQUENCE   329 AA;  35870 MW;  E121ADB7C5BD9CF8 CRC64;
     MVRTKTWTLK KHFVGYPTNS DFELKTAELP PLKNGEVLLE ALFLTVDPYM RVAAKRLKEG
     DTMMGQQVAK VVESKNVALP KGTIVLASPG WTTHSISDGK DLEKLLTEWP DTIPLSLALG
     TVGMPGLTAY FGLLEICGVK GGETVMVNAA AGAVGSVVGQ IAKLKGCKVV GAVGSDEKVA
     YLQKLGFDVV FNYKTVESLE ETLKKASPDG YDCYFDNVGG EFSNTVIGQM KKFGRIAICG
     AISTYNRTGP LPPGPPPEIV IYQELRMEAF VVYRWQGDAR QKALKDLLKW VLEGKIQYKE
     YIIEGFENMP AAFMGMLKGD NLGKTIVKA
//
